I thought about buying some of this garbage around $100 on the way up, but I changed my mind when I found that Cramer was touting it. That was enough to turn me off. Same for GPRO. I learned a long time ago to stay clear of anything that Cramer is touting.
Wrong. The recent weakness is lack of buyers. If the sellers (short or long, makes no difference) are more numerous and motivated than the buyers, the price falls. It's just that simple. Don't blame everything on the short sellers. In this case, they've been on the right side. Many more people are selling long than selling short, and too few people are stepping up to buy (except Dr. Frost.)
Anyone trading ETFs, especially the thinly traded ones, should protect themselves with "limit" orders ONLY. DO NOT use "market" orders unless you don't mind being robbed. The flash crash of last Monday should be a wake-up call to the vagaries of the ETF market. Net asset values are meaningless. Mutual fund investors have to change their mentality completely when using ETFs. The ability to use "limit" and "open" orders is a huge benefit that ETFs have over their older, open-end cousins, but you have to be careful. Don't assume you'll get NAV or anything close to it. Monday (8/24/15) should have taught everyone that simple lesson.
Anyone trading the MLPs would be well advised to use limit orders only. Crazy volatility has become the norm, and sellers in particular are getting creamed. Protect yourself with limit orders if you don't want to get robbed.
I contend that the shorts are NOT in control of anything. Rather, it is poor investor sentiment that is in control, along with a generally dismal overall market. Sellers are in control. Shorts are irrelevant. Sellers, whether short or long, matters not. Short sellers eventually have to buy to cover, so it could be argued that they help the stock. FDA decisions (approvals) will have very little impact on the stock any more than the completion of the BRLI takeover had. I'm long, so I really don't care.
If that's true, this is BIG news. Secondary insurance, i.e. AARP United Healthcare, will cover what Medicare does not pay. The critical thing is that Medicare must first approve coverage. This was the last hurdle if the test has Medicare approval. I've had 2 biopsies, and they were both the worst pain I've ever experienced. I now call my urologist Vlad, as in Vlad - the Impaler (Prince of Wallachia). I'm just wondering why the stock hasn't reacted.
IMO, the entire selloff in the MLPs has been almost entirely unjustified. One day they go down because oil is down. The next day they go up because oil is down. There's a disconnect that defies logic. I've given up trying to make sense of it.
Probably a combination of both. If he had not bought, it would be around $2 today. When he stopped buying for a few weeks in the mid-teens, the price plunged. Without Frost, there's no Opko.
Agree, but at the time they were both thought to be world-changers. You're looking back at history I can't say when, but AAPL will eventually run out of steam. Opko will be taken over and be swallowed by a MRK or PFE. Frost is not going to live forever.
I disagree with both. AAPL's best days are behind it. OPK will only last as long as Philip Frost. You've been brain-washed. I remember when people were saying the same thing about Polaroid and Enron.
Yahoo is a disaster when it comes to accurate information. Even when glaring errors are brought to their attention, they are apparently incapable of making corrections. WARNING: Do not depend on Yahoo historical pricing information for tax or other preparation.
Anything is possible, but I have a feeling we've seen the low. As it moves up to the mid-teens, I expect to see lots of sellers looking to get out even. Once it hits a new high, the sky's the limit. It'll take time, but as long as Dr. Frost's health holds up, I expect to see a gradual recovery. 20 is the magic number. 20 goes straight into 30.
I agree totally. There are many on this board who obviously don't have a clue what a "short squeeze" actually is. The reality is that OPK has never even come close to reaching short squeeze territory. Even with all the pumping and hyping and touting, the market in Opko stock was orderly and balanced. Some margin calls may have gone out, but they were probably few. The ability to borrow stock was never a problem. With the price up a whooping $1 since the recent low, a short squeeze is pure fantasy. Especially with far more shares outstanding as the result of the takeover of BioRefLabs. Why do I even waste my time reading this dribble?
Lots of downgrades on pipes from U.S. Capital including MMP. EPD remains one of their top picks (no downgrade on that name.) There's plenty of negativity to go around. That said, I still have a very low opinion of analysts of all stripes.
Because they can. They're government bureaucrats. It's in their DNA. They think they're not doing their job if they don't arbitrarily reject or delay some applications for some nebulous reason that only they know. Have you ever dealt with your state DMV? Seeing me makes them hungry. They always go out to lunch as soon as I get to the front of the line.